MCH ADVISORY RESEARCH
Health Care

Life Sciences Tools & Services

8 companies under coverage.

Coverage

Life Sciences Tools & Services


Equity Research

Agilent Technologies Inc (A)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $236, +78% vs spot. It needs the multiple to hold or expand.

AEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -5%
Equity Research

Danaher Corporation (DHR)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $343, +80% vs spot. It needs the multiple to hold or expand.

DHREquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -7%
Equity Research

Thermo Fisher Scientific Inc (TMO)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $908, +81% vs spot. It needs the multiple to hold or expand.

TMOEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -8%
Equity Research

Bio-Techne Corp (TECH)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $126, +79% vs spot. It needs the multiple to hold or expand.

TECHEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -10%
Equity Research

Waters Corporation (WAT)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $678, +81% vs spot. It needs the multiple to hold or expand.

WATEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -11%
Equity Research

Mettler-Toledo International Inc (MTD)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $2,225, +74% vs spot. It needs the multiple to hold or expand.

MTDEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -12%
Equity Research

IQVIA Holdings Inc (IQV)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $341, +77% vs spot. It needs Gross Margin to surprise to the upside.

IQVEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -13%
Equity Research

Charles River Laboratories (CRL)

The bull case — 'Bull — Re-Rate' (8% weight) — targets $374, +65% vs spot. It needs the multiple to hold or expand.

CRLEquity ResearchMonte Carlo
1 July 2026Rating: HOLD · -19%
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v3.2 · US-listed comparatives · UK English